<
Chinese pharmaceutical companies increased by ten times the overseas mergers and acquisitions in the third quarter
Release time: 2014-11-18 & nbsp & nbsp & nbsp Source: Anonymous
    Pharmaceutical Network November 10 News Since 2014, Global Medical Big Medical Giants Norhua、Glaxo Sonsk、Pfizer and Johnson & Johnson have opened the merger and acquisition plan,The stake betting appmedical and health industry has set off a new round of unprecedented mergers and acquisitions。Data monitoring by the Research Department of Morning Penti Group,Chinese pharmaceutical companies have also obtained a lot of funds through their own accumulation or capital market,Moving to accelerate the development of development through overseas mergers and acquisitions in the third quarter of this year。
 
Morning whistle thinks,At present, the pharmaceutical stake betting appStake Sports Bettingindustry is in a period of rapid development,Each subdivided medical field has strong overall profitability,And the field of biopharmaceuticals and medical equipment has always been the focus of the pharmaceutical industry。According to the data of the "2014 Chinese Overseas M & A Report" released by the Research Department of the Morning Penti Group on October 30,Biopharmaceuticals in the third quarter、M & A for medical devices and medical services is particularly active。A total of 6 overseas mergers and acquisitions have occurred in the Chinese stake betting appmedical and health industry,5 of which disclosed the transaction amount,Discovery total amount of 622 million US dollars,Compared with the second quarter statistics, 2 overseas mergers and acquisitions of US $ 52 million disclosure increased by 10 times。
 
Active mergers and acquisitions of biopharmaceuticals and medical devices
 
In the field of biopharmaceuticals,The most noticed buyer is Zhongheng Group Holding subsidiary Guangxi Wuzhou Pharmaceutical Co., Ltd.。Its on August 12,Within 11 million US dollars in one day, two Pharmaceutical Factory of Israel,is ORAMED and Integra。Morning whistle thinks,Chinese diabetes patients ranked first in the world,Diabetes -related drugs are huge。Zhongheng Group is the diabetic drugs and R & D projects of two Israeli pharmaceutical companies,The field of active layout of diabetic drugs is acquired。
 
In the field of research and development and manufacturing in medical device,Beijing Ledman Biochemical Co.My stake betting app, stake online sports bettingLtd. acquired some equity in Dedai, Germany on September 15,After the transaction will be completed, it will hold the Dedai system and the Dedai product 25%、31%equity。Morning whistle analyst said,This transaction shows that people's attention to physical health is gradually increased,The medical diagnosis system can help people confirm the types of various diseases,Various body fluids of the human body、Cell、An reagent for tissue samples,It is closely related to people's health,For example, people detect the pathogen during physical examination、antibody、Query blood type、Genes and genetic diseases require in vitro diagnostic reagents for testing。The in vitro diagnostic market may become a high -incidence area in the future,Companies that have occupied a seat in the in vitro diagnostic market will give priority to actively expanding their market share。
Fosun continues to deploy the medical service industry worldwide
 
Global aging acceleration has prompted the demand for medical services to steadily increase,The medical service industry focusing on the elderly has become the new hot spot for investment mergers and acquisitions in the third quarter。
 
September 23,Fosun International Co., Ltd. passed the quotation of about 451 million euros through its Portuguese insurance company Fidelidade,Send a comprehensive acquisition offer to Portuguese medical service provider ESS。On October 16th Fosun International Co., Ltd. issued an announcement to acquire more than 96%of the right to obtain 96%voting stake betting apprights for 460 million euros。
 
stake sports betting appESS is a Portuguese mainly engaged in operating emergency care hospitals、Outpatient Clinic、Inpatient hospital、Service Elderly Accommodation and the Holding Company of the Medical Care Corporation of the National Health Service System Public and Private Companion Hospital,Currently listed on the Lisbon European European Exchange。
 
Morning whistle analyst said,This acquisition shows that China's pharmaceutical companies have begun to turn their attention to the medical service industry,The medical service industry is about to enter the rapid growth period。Observation based on the Research Department of the Morning Pental Group,From the asset status of ESS company itself,It also revealed the focus point of Fosun Overseas Investment & MDASH; Stepping on the acquisition of large medical and large health assets。
 
Previous February,Fosun Pharmaceuticals through mutual benefit to the United States and China,Direct Holding High -end Medical Service Institution Human Mujia Hospital,Deeply cut into the high -end medical service field。It can complement the existing medical service layout of Fosun Pharmaceutical,Increase the control of the Human Hospital,For subsequent operations、Management、The layout is good,Increase the capital strength of the harmonious family through capital increase,It can accelerate its in first -tier cities、The layout of high -end medical services in the economy and developed cities。
 
Looking at the overseas M & A trend of the overall stake betting appmedical and health industry in the third quarter of 2014,stake online sports bettingMorning whistle believes that due to the acceleration of the global population aging and people's attention to health,China's medical and health industry overseas acquisitions will inevitably accelerate。